Europe and Northern America vs Saudi Arabia: Percentage of bloodstream infection due to methicillin-resistant
Europe and Northern America
8.0%
in 2022
Saudi Arabia
52.0%
in 2022
Europe and Northern America rank
14th
Saudi Arabia rank
12th
Percentage of bloodstream infection due to methicillin-resistant over time
- Europe and Northern America
- Saudi Arabia
How they compare
Saudi Arabia currently reports 52.0% against 8.0% in Europe and Northern America, a difference of 44.0%.
That makes Saudi Arabia's figure about 6.5 times Europe and Northern America's.
Across all 6 years both countries report, Saudi Arabia has been ahead every year.
Europe and Northern America ranks 14th and Saudi Arabia ranks 12th of 15 groups.
Saudi Arabia has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Europe and Northern America | Saudi Arabia | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 14.2% | 42.8% | 28.7% | Saudi Arabia |
| 2020s | 8.5% | 67.5% | 58.9% | Saudi Arabia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher percentage of bloodstream infection due to methicillin-resistant, Europe and Northern America or Saudi Arabia?
- Saudi Arabia, at 52.0% against 8.0% in Europe and Northern America as of 2022.
- What is the difference in percentage of bloodstream infection due to methicillin-resistant between Europe and Northern America and Saudi Arabia?
- 44.0%, with Saudi Arabia ahead.
- How many years of comparable data are there for Europe and Northern America and Saudi Arabia?
- 6 years are reported by both, from 2017 to 2022.
- How do Europe and Northern America and Saudi Arabia rank globally for percentage of bloodstream infection due to methicillin-resistant?
- Europe and Northern America ranks 14th and Saudi Arabia ranks 12th of 15 groups.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.